NasdaqGM - Nasdaq Real Time Price USD

Zentalis Pharmaceuticals, Inc. (ZNTL)

1.2500
-0.0100
(-0.79%)
At close: May 19 at 4:00:00 PM EDT
1.2700
+0.02
+(1.60%)
After hours: May 19 at 5:24:19 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
26,865
67,425
0
0
0
Operating Expense
227,385
254,883
253,941
227,287
216,542
Operating Income
-200,520
-187,458
-253,941
-227,287
-216,542
Other Income Expense
-23,632
21,768
-22,951
5,987
51,983
Pretax Income
-224,152
-165,690
-276,892
-221,300
-164,559
Tax Provision
34
177
-601
-469
-297
Earnings from Equity Interest Net of Tax
--
0
-16,014
-16,282
-1,831
Net Income Common Stockholders
-224,186
-165,839
-292,191
-236,806
-158,725
Diluted NI Available to Com Stockholders
-224,186
-165,839
-292,191
-236,806
-158,725
Basic EPS
-3.14
--
-4.47
-4.48
-3.72
Diluted EPS
-3.14
--
-4.47
-4.48
-3.72
Basic Average Shares
71,275
--
65,409
52,857
42,688
Diluted Average Shares
71,275
--
65,409
52,857
42,688
Total Operating Income as Reported
-212,052
-191,194
-299,509
-227,287
-216,542
Total Expenses
227,385
254,883
253,941
227,287
216,542
Net Income from Continuing & Discontinued Operation
-224,186
-165,839
-292,191
-236,806
-158,725
Normalized Income
-205,516.7200
-183,035.7200
-269,285.9020
-242,781.0260
-210,604.0340
EBIT
-200,520
-187,458
-253,941
-227,287
-216,542
EBITDA
-199,293
-186,169
-252,552
-225,861
-215,998
Reconciled Depreciation
1,227
1,289
1,389
1,426
544
Net Income from Continuing Operation Net Minority Interest
-224,186
-165,839
-292,191
-236,806
-158,725
Total Unusual Items Excluding Goodwill
-23,632
21,768
-22,951
5,987
51,983
Total Unusual Items
-23,632
21,768
-22,951
5,987
51,983
Normalized EBITDA
-175,661
-207,937
-229,601
-231,848
-267,981
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
-4,962.7200
4,571.2800
-45.9020
11.9740
103.9660
12/31/2021 - 4/3/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ORIC ORIC Pharmaceuticals, Inc.
5.14
+8.67%
 
PMVP PMV Pharmaceuticals, Inc.
0.8740
+0.94%
 
RLAY Relay Therapeutics, Inc.
2.9300
+4.27%
 
ACRV Acrivon Therapeutics, Inc.
1.1800
+2.61%
 
KROS Keros Therapeutics, Inc.
14.10
+0.21%
 
ARTV Artiva Biotherapeutics, Inc.
2.0200
-0.49%
 
ALXO ALX Oncology Holdings Inc.
0.4313
-1.39%
 
OLMA Olema Pharmaceuticals, Inc.
4.8000
+1.91%
 
FDMT 4D Molecular Therapeutics, Inc.
3.8000
+10.47%
 
OKUR OnKure Therapeutics, Inc.
2.2000
+10.00%